ArticleCellular oncology (Dordrecht, Netherlands)2023

PKMYT1 inhibits lung adenocarcinoma progression by abrogating AKT1 activity.

Shuang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.